Site-specific in vivo targeting of magnetoliposomes using externally applied magnetic field

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 55, Issue 3-4, 2000, Pages 278-281

  Babincová, Melánia ^a   Altanerová, Veronika ^b   Lampert, Miloš ^c   Altaner, Čestmír ^b   Machová, Eva ^b   Šrámka, Miron ^c   Babinec, Peter ^a  

^a Physics and Informatics   (Slovakia)

^b INSTITUTE OF CHEMISTRY   (Slovakia)

^c Derer 's University Hospital Slovakia   (Slovakia)

Author keywords

Drug Targeting; Kidney Center; Magnetoliposomes

Indexed keywords

DRUG DELIVERY SYSTEM; IN VIVO STUDY; KIDNEY; LIPOSOME; MAGNETIC FIELD; MAGNETOLIPOSOME; PARTICLE; RADIOACTIVITY; RAT;

EID: 0034064420     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2000-3-422     Document Type: Article

References (19)

1. Babincová M. (1993), Microwave induced leakage of magnetoliposomes: possible clinical implications. Bioelectrochem. Bioenerg. 32, 187-190.
2. Babincová M. and Babinec P. (1997), Controlled drug delivery using magnetoliposomes. Cell. Mol. Biol. Lett. 2, 3-10.
3. Babincová M. and Machová E. (1998), Magnetoliposomes may be useful for elimination of HIV from infected individuals. Z. Naturforsch. 53c, 935-936.
4. Babincová M., Sourivong P., Chorvát D. and Babinec P. (1999), Laser triggered drug release from magnetoliposomes. J. Mag. Magn. Mat. 194, 163-167.
5. Brown J. M. and Giaccia A. J. (1998), The unique physiology of solid tumors: opportunities (and prob- lems) for cancer therapy. Cancer Res. 58, 1408-1416.
6. Bulte J. W., de Cuyper M., Despres D. and Frank J. A. (1999), Short-vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents. J. Magn. Reson. Imaging 9, 329-325.
7. Figlin R. A. (1999), Renal cell carcinoma: management of advanced disease. J. Urol. 161, 381-386.
8. Goins B., Phillips W. T. and Klipper R. (1996), Blood-pool imaging using technetium-99m-labeled liposomes. J. Nucl. Med. 37, 1374-1379.
9. Häfeli U., Pauer G. J., Roberts W. K., Humm J. L. and Macklis R. M. (1997), Magnetically targeted microspheres for intracavitary and intraspinal Y-90 radiotherapy. In: Scientific and Clinical Applications of Magnetic Carriers (Häfeli U. ed.). Plenum Press, New York.
10. Kobayashi K., Han M., Watarai S. and Yasuda T. (1996), Availability of liposomes as drug carriers to the brain. Acta Med. Okayama 50, 67-72.
11. Lasic D. D. (1997), Novel applications of liposomes. Trends Biotechnol. 16, 307-321.
12. Liu D., Hu Q. and Song Y. K. (1995), Liposome clearance from blood: different animal species have different mechanisms. Biochim. Biophys. Acta 1240, 277-284.
13. Phillips W. T., Rudolph A. S., Goins B., Timmons J. H., Klipper R. and Blumhardt R. (1992) A simple method for producing a technetium-99m-labeled liposome which is stable in vivo. Int. J. Rad. Appl. Instrum. [B] 19, 539-547.
14. Scherphof G., Roerdink G., Waite M. and Parks J. (1978), Disintegration of phosphatidylcholine liposomes in plasma as result of interaction with high-density lipoproteins. Biochim. Biophys. Acta 542, 296-304.
15. Schütt W., Grüttner C., Häfeli U., Zborowski M., Teller J., Putzar H. and Schümichen C. (1997), Applications of magnetic targeting in diagnosis and therapy: Possibilities and limitations. Hybridoma 16, 109-117.
16. Shinkai M., Suzuki M., Iijima S. and Kobayashi T. (1994), Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia. Biotechnol. Appl. Biochem. 21, 125-137.
17. Siegall C. B. (1994), Targeted toxins as anticancer agents. Cancer 74, 1006-1012.
18. Viroonchatapan E., Ueno M., Sato H., Adachi I., Nagae H., Tazawa K. and Horikoshi I. (1995), Preparation and characterization of dextran magnetite-incorporated thermosensitive liposomes: an on-line flow system for quantifying magnetic responsiveness. Pharm. Res. 12, 1176-1183.
19. Viroonchatapan E., Sato H., Ueno M., Adachi I., Tazawa K. and Horikoshi I. (1996), Magnetic targeting of thermosensitive magnetoliposomes to mouse livers in an in situ on-line perfusion system. Life Sci. 58, 2251-2261.